0001209191-22-033163.txt : 20220601 0001209191-22-033163.hdr.sgml : 20220601 20220601162752 ACCESSION NUMBER: 0001209191-22-033163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOWEN MAXINE CENTRAL INDEX KEY: 0001280044 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39231 FILM NUMBER: 22987720 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-31 0 0001787297 Passage BIO, Inc. PASG 0001280044 GOWEN MAXINE ONE COMMERCE SQUARE 39TH FLOOR PHILADELPHIA PA 19103 1 0 0 0 Stock Option (Right to Buy) 1.80 2022-05-31 4 A 0 40000 0.00 A 2032-05-30 Common Stock 40000 40000 D The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date. /s/ Edgar Cale, Attorney-in-Fact 2022-06-01